Literature DB >> 19768653

Secondary disorders of glycosylation in inborn errors of fructose metabolism.

E Quintana1, L Sturiale, R Montero, F Andrade, C Fernandez, M L Couce, R Barone, L Aldamiz-Echevarria, A Ribes, R Artuch, P Briones.   

Abstract

Adamowicz and colleagues raised the alert in 2007 about patients with atypical hereditary fructose intolerance (HFI) primarily misdiagnosed as CDG Ix. We describe a girl with neonatal hypertonia, facial trismus, absent swallowing and coughing reflexes, gastro-oesophageal reflux and sporadically elevated Krebs cycle metabolites and lactate. At 14 months microcephaly and hepatomegaly were noted, with hypertransaminasaemia but normal blood coagulation, glucose, phosphate, and absent urinary reducing substances. Neurological impairment persisted. Because of hepatic and neurological abnormalities with developmental delay, Tf IEF was performed and showed a severe type 1 pattern, resulting in a wrong diagnosis of CDG. Subsequently, an aversion to fruits suggested HFI, confirmed by the finding of ALDOB mutations (p.A150P/p.N335K). The girl improved with fructose-free diet, but liver cirrhosis led to hepatic transplantation. She is now 7 years old with good evolution; facial trismus and hypertonia reversed, but microcephaly persists. Transferrin MALDI-TOF MS characterization revealed underoccupation of glycosylation sites and glycan abnormalities, which reversed with dietary treatment. High maternal fructose concentrations might have caused neonatal abnormalities. Although in our patient's mother there is no fructose accumulation at present, it is possible that increased ingestion of fruits and vegetables during pregnancy, together with her heterozygosity, caused an accumulation of fructose that finally affected the fetus. We also describe slightly abnormal transferrin isoelectric focusing and MALDI-TOF MS patterns of intact transferrin and N-glycans in a fructose-1,6-bisphosphatase (FBP1)-deficient patient. While HFI is a well-known cause of secondary CDG, we found no reports of abnormal transferrin isoelectric focusing patterns in FBP1 deficiency and we introduce this condition as a possible secondary cause for altered transferrin isoelectric focusing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19768653     DOI: 10.1007/s10545-009-1219-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain.

Authors:  J C Sánchez-Gutiérrez; T Benlloch; M A Leal; B Samper; I García-Ripoll; J E Felíu
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

2.  Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome.

Authors:  Y Wada; A Nishikawa; N Okamoto; K Inui; H Tsukamoto; S Okada; N Taniguchi
Journal:  Biochem Biophys Res Commun       Date:  1992-12-15       Impact factor: 3.575

3.  Transferrin hypoglycosylation in hereditary fructose intolerance: using the clues and avoiding the pitfalls.

Authors:  M Adamowicz; R Płoski; D Rokicki; E Morava; M Gizewska; H Mierzewska; A Pollak; D J Lefeber; R A Wevers; E Pronicka
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

4.  Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis.

Authors:  Willy Morelle; Christophe Flahaut; Jean-Claude Michalski; Alexandre Louvet; Philippe Mathurin; André Klein
Journal:  Glycobiology       Date:  2005-12-08       Impact factor: 4.313

5.  Personal experience with the application of carbohydrate-deficient transferrin (CDT) assays to the detection of congenital disorders of glycosylation.

Authors:  C Colomé; I Ferrer; R Artuch; M A Vilaseca; M Pineda; P Briones
Journal:  Clin Chem Lab Med       Date:  2000-10       Impact factor: 3.694

6.  Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Melissa Lowman; Ronald E Long; Jonathan Krakover; Ramila Philip; Steven Seeholzer; Alison A Evans; Hie-Won L Hann; Timothy M Block; Anand S Mehta
Journal:  J Proteome Res       Date:  2006-02       Impact factor: 4.466

7.  Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance.

Authors:  J Jaeken; M Pirard; M Adamowicz; E Pronicka; E van Schaftingen
Journal:  Pediatr Res       Date:  1996-11       Impact factor: 3.756

8.  Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.

Authors:  Luisa Sturiale; Rita Barone; Agata Fiumara; Marta Perez; Marco Zaffanello; Giovanni Sorge; Lorenzo Pavone; Silvia Tortorelli; John F O'Brien; Jaak Jaeken; Domenico Garozzo
Journal:  Glycobiology       Date:  2005-07-21       Impact factor: 4.313

9.  Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis.

Authors:  Suzan Wopereis; Stephanie Grünewald; Eva Morava; Johannes M Penzien; Paz Briones; M Teresa García-Silva; Pierre N M Demacker; Karin M L C Huijben; Ron A Wevers
Journal:  Clin Chem       Date:  2003-11       Impact factor: 8.327

  9 in total
  9 in total

Review 1.  The biochemical basis of hereditary fructose intolerance.

Authors:  Nadia Bouteldja; David J Timson
Journal:  J Inherit Metab Dis       Date:  2010-02-17       Impact factor: 4.982

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

Review 3.  Novel techniques and newer markers for the evaluation of "proximal tubular dysfunction".

Authors:  Michael Ludwig; Sidharth K Sethi
Journal:  Int Urol Nephrol       Date:  2011-03-01       Impact factor: 2.370

4.  Prevalence of Congenital Disorders of Glycosylation in Childhood Epilepsy and Effects of Anti-Epileptic Drugs on the Transferrin Isoelectric Focusing Test.

Authors:  Grace Silver; Shalini Bahl; Dawn Cordeiro; Abhinav Thakral; Taryn Athey; Saadet Mercimek-Andrews
Journal:  Genes (Basel)       Date:  2021-08-10       Impact factor: 4.096

5.  Increased carbohydrate deficient transferrin: Whisky or candy?

Authors:  Baptiste Giguet; Arnaud Bruneel; Sandrine Vuillaumier Barrot; Romain Moirand; Edouard Bardou Jacquet
Journal:  JHEP Rep       Date:  2022-04-20

Review 6.  Impact of pregnancy on inborn errors of metabolism.

Authors:  Gisela Wilcox
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

7.  Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review.

Authors:  Rossella Colantuono; Elisa D'Acunto; Daniela Melis; Pietro Vajro; Hudson H Freeze; Claudia Mandato
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-10-01       Impact factor: 3.288

8.  Unveiling the metabolic fate of monosaccharides in cell membranes with glycomic and glycoproteomic analyses.

Authors:  Gege Xu; Maurice Wong; Qiongyu Li; Dayoung Park; Zhi Cheng; Carlito B Lebrilla
Journal:  Chem Sci       Date:  2019-06-11       Impact factor: 9.825

9.  Transferrin isoelectric focusing for the investigation of congenital disorders of glycosylation: analysis of a ten-year experience in a Brazilian center.

Authors:  Ana Paula Pereira Scholz de Magalhães; Maira Graeff Burin; Carolina Fischinger Moura de Souza; Fernanda Hendges de Bitencourt; Fernanda Medeiros Sebastião; Thiago Oliveira Silva; Filippo Pinto E Vairo; Ida Vanessa Doederlein Schwartz
Journal:  J Pediatr (Rio J)       Date:  2019-10-31       Impact factor: 2.990

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.